A cloud-based computing platform has been launched for use in the medical and scientific sectors that specifically provides access to a variety of genomic and phenotypic data.
GenoSpace was developed after its founders recognised that the rapidly falling cost of genome sequencing would make existing systems obsolete. As a result, they developed a cloud-based data storage and "software-as-a-service" platform based on a robust, scalable, and secure data model.
The two founders, John Quackenbush and Mick Correll, used their experience of creating software systems that linked clinical and research data to develop the system, which has collection of intuitive, informative, data-access portals that cater to the needs of a wide range of users.
The chairman of the GenoSpace board of directors, Joseph Boystak, said that the scope of the new system is enormous.
“GenoSpace has tremendous commercial potential, including recurring revenue streams, by its offering clients and constituents high value-added products and services,” he said. “This is the first company to create an information ecosystem that links together diverse users in ways that can benefit everyone involved. GenoSpace offers the solution for 21st-century genomic medicine.”
Mr Correll, who now sits as the company’s chief technology officer, added, “Our cloud-based technology is secure, robust, and infinitely scalable, and the portals we've developed are aimed at solving problems people have today, while being adaptable to the needs of genomic medicine tomorrow.”
http://www.kirkhamyoung.co.uk/news/article/cloudbased-diagnostics-service-launched-184854.html
No comments:
Post a Comment